|
ATF6 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.60800000000339E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.350800E-04 |
| Normal-vs-Stage2 |
5.602500E-04 |
| Normal-vs-Stage3 |
1.88164999999074E-05 |
| Normal-vs-Stage4 |
1.238240E-03 |
| Stage1-vs-Stage2 |
3.952200E-01 |
| Stage1-vs-Stage3 |
2.348800E-01 |
| Stage1-vs-Stage4 |
5.742600E-01 |
| Stage2-vs-Stage3 |
9.995000E-01 |
| Stage2-vs-Stage4 |
8.080600E-01 |
| Stage3-vs-Stage4 |
7.583200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.43409999999878E-05 |
| Normal-vs-AfricanAmerican |
1.949200E-01 |
| Normal-vs-Asian |
1.981310E-03 |
| Caucasian-vs-AfricanAmerican |
1.466610E-01 |
| Caucasian-vs-Asian |
9.677200E-01 |
| AfricanAmerican-vs-Asian |
1.987220E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.82443999999782E-05 |
| Normal-vs-Female |
3.178100E-04 |
| Male-vs-Female |
1.346440E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.819500E-03 |
| Normal-vs-Age(41-60Yrs) |
2.07009999999563E-05 |
| Normal-vs-Age(61-80Yrs) |
1.376520E-04 |
| Normal-vs-Age(81-100Yrs) |
3.852200E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.084200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.370400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.828400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.414400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.758000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.545200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.222620E-01 |
| Classical-VS-Follicular |
1.622210E-03 |
| Classical-VS-Other |
5.728200E-02 |
| Classical-VS-Normal |
2.764400E-03 |
| Tall-VS-Follicular |
3.058600E-01 |
| Tall-VS-Other |
9.894000E-02 |
| Tall-VS-Normal |
6.578100E-04 |
| Follicular-VS-Other |
4.437600E-01 |
| Follicular-VS-Normal |
2.55400000004347E-06 |
| Other-VS-Normal |
1.300210E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.57852999999042E-05 |
| Normal-vs-N1 |
7.84670000000265E-05 |
| N0-vs-N1 |
4.592800E-01 |
|
|
